Latest Updates
Read the latest news that impacts the oncology community.
ASCO Updates Policy Statement on 340B Drug Pricing Program
The update proposes a package of recommendations to expand practice eligibility, address potential abuses, and ensure the 340B program benefits the patients it was intended to serve.
Read MorePrivate Medicare Plans Often Deny Access to Rehab Care, Analysis Shows
People enrolled in private Medicare Advantage plans have been inappropriately denied admission to a skilled nursing home when leaving the hospital, according to a new analysis by federal investigators.
Read MoreMedicare Advantage Organizations Overturned Nearly All Appealed Prior Authorization Denials for Skilled Nursing Facility Admission, Raising Concerns About Initial Denials
People who are eligible for benefits under original Medicare may choose to receive their Medicare coverage through Medicare Advantage plans administered by Medicare Advantage organizations (MAOs). In 2024, 54 percent of people with Medicare (32.8 million people) were enrolled in Medicare Advantage, and the Centers for Medicare & Medicaid Services (CMS) paid MAOs an estimated $494 billion.
Read MoreThe Three Largest Medicare Advantage Organizations Denied Requests for Long-Term Acute Care and Inpatient Rehabilitation at Some of the Highest Rates
Previous OIG work raised concerns that Medicare Advantage organizations’ (MAOs’) use of prior authorization can in some cases result in denials and delays in access to needed care for enrollees. MAOs that inappropriately deny care are not delivering the full value that taxpayers pay them to provide.
Read MoreRob Sand says audit shows PBMs may be overcharging Iowa taxpayers
State Auditor Rob Sand said pharmacy benefit managers who work with Iowa's Medicaid program appear to be overcharging taxpayers by using prohibited pricing techniques.
Read MoreSpecial Report: The Oncology Care Model, 10 Years Later
July 1, 2026, will mark 10 years since the start of the Oncology Care Model (OCM), an anniversary that might have seemed less celebratory just a few years ago, but one that is gaining notice, as the influence of the signature model of the Center for Medicare and Medicaid Innovation (CMMI) is felt across cancer care.
Read MoreHow Oncologists Are Using Electronic PROs to Improve Cancer Care
My name is Dr. Debra Patt. I serve as an executive vice president of Texas Oncology, which is part of the US Oncology Network, and I serve as the president of the Community Oncology Alliance. I’m really excited to talk with you today.
Read MoreM&A surging in PBM sector as smaller companies seek edge
The pharmacy benefit manager sector is undergoing a resorting as mergers and closures accumulate.
Read MoreEli Lilly's claims data deadline may kick off new 340B fight
Eli Lilly’s deadline has passed for hospitals to comply with its new 340B claims data policy, and for now the pharma company is staying mum
Read More340B program: Hospital discount drug reform plan heads to Pritzker
SPRINGFIELD, Ill. (WAND) — A plan heading to Gov. JB Pritzker's desk could help lower drug prices by regulating 340B contracts.
Read More